AlphaSimPlex Group’s AbbVie ABBV Stock Holding History

AlphaSimPlex Group’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$255K	Buy	+1,898	New	+$272K	2.58%	14
2022 Q2	–	Sell	-1,914	Closed	-$310K	–	50
2022 Q1	$310K	Sell	1,914 -916	-32%	-$133K	1.14%	27
2021 Q4	$383K	Sell	2,830 -8,009	-74%	-$946K	0.65%	50
2021 Q3	$1.17M	Sell	10,839 -3,560	-25%	-$407K	0.97%	24
2021 Q2	$1.62M	Hold	14,399	–	–	0.81%	28
2021 Q1	$1.56M	Buy	+14,399	New	+$1.54M	0.65%	37

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

AlphaSimPlex Group's ABBV Position: Q3 2022 in Review

AlphaSimPlex Group opened a new position in AbbVie (ABBV) in Q3 2022: 1,898 shares worth $255K. The stake represents 2.58% of the portfolio and ranks #14 among its holdings. This is a return to the name: AlphaSimPlex Group previously reported a position in ABBV as recently as Q1 2022.

AlphaSimPlex Group first reported a position in ABBV in Q1 2021 and has held it in 6 quarters since. The position peaked at $1.62M in Q2 2021. 2,968 funds tracked by Wall St. Rank hold ABBV as of Q3 2022.

AlphaSimPlex Group held 1,898 shares of AbbVie worth $255K as of Q3 2022.
AbbVie was a new AlphaSimPlex Group position in Q3 2022.
AbbVie made up 2.58% of AlphaSimPlex Group's portfolio in Q3 2022, its #14 holding.
AlphaSimPlex Group first reported a position in AbbVie in Q1 2021 and has held it in 6 quarters since.
AlphaSimPlex Group's AbbVie position peaked at $1.62M in Q2 2021.
2,968 funds tracked by Wall St. Rank held AbbVie as of Q3 2022.

Based on AlphaSimPlex Group's 13F filing for Q3 2022, filed 8 Nov 2022.